Eastwood Bio-Medical Research Inc

Eastwood Bio-Medical Research Inc. (EBMR) is a privately owned Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus (NIDDM-Type II diabetes) , obesity and hypertension. EBMR's core technologies include the NIDDM treatment, known as ELEOTIN®. Located in Vancouver, EBMR is currently commercializing a patented **0% natural herbal treatment for controlling and regulating blood glucose levels. Initially developed at the Julia McFarlane Diabetes Research Centre, ELEOTIN®has undergone numerous tests involving both animal and human subjects in various research facilities. ELEOTIN® has been proven to be safe and effective in the improvement of blood glucose levels in NIDDM patients.